SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
12195132
Source:
http://linkedlifedata.com/resource/pubmed/id/12195132
Search
Subject
(
70
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0011847
,
umls-concept:C0020538
,
umls-concept:C0035647
,
umls-concept:C0126174
,
umls-concept:C0301630
,
umls-concept:C1948041
,
umls-concept:C2349179
,
umls-concept:C2603343
pubmed:issue
9
pubmed:dateCreated
2002-8-26
pubmed:abstractText
There has been uncertainty about the risk of new-onset diabetes in hypertensive individuals treated with different blood pressure-decreasing drugs.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/8306882
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antihypertensive Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Atenolol
,
http://linkedlifedata.com/resource/pubmed/chemical/Losartan
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0263-6352
pubmed:author
pubmed-author:AurupPeterP
,
pubmed-author:BeeversGarethG
,
pubmed-author:Borch-JohnsenKnutK
,
pubmed-author:DahlöfBjörnB
,
pubmed-author:DevereuxRichard BRB
,
pubmed-author:EdelmanJonathan MJM
,
pubmed-author:FyhrquistFrejF
,
pubmed-author:IbsenHansH
,
pubmed-author:JuliusStevoS
,
pubmed-author:KjeldsenSverre ESE
,
pubmed-author:KristiansonKristerK
,
pubmed-author:LIFE study group
,
pubmed-author:Lederballe-PedersenOleO
,
pubmed-author:LindholmLars HLH
,
pubmed-author:NieminenMarkku SMS
,
pubmed-author:OlsenMichael HechtMH
,
pubmed-author:OparilSuzanneS
,
pubmed-author:OpdamHH
,
pubmed-author:SnapinnStevenS
,
pubmed-author:WachtellKristianK
,
pubmed-author:WedelHansH
,
pubmed-author:de FaireUlfU
pubmed:issnType
Print
pubmed:volume
20
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1879-86
pubmed:dateRevised
2009-6-29
pubmed:meshHeading
pubmed-meshheading:12195132-Aged
,
pubmed-meshheading:12195132-Aged, 80 and over
,
pubmed-meshheading:12195132-Antihypertensive Agents
,
pubmed-meshheading:12195132-Atenolol
,
pubmed-meshheading:12195132-Diabetes Mellitus
,
pubmed-meshheading:12195132-Double-Blind Method
,
pubmed-meshheading:12195132-Humans
,
pubmed-meshheading:12195132-Hypertension
,
pubmed-meshheading:12195132-Hypertrophy, Left Ventricular
,
pubmed-meshheading:12195132-Incidence
,
pubmed-meshheading:12195132-Losartan
,
pubmed-meshheading:12195132-Middle Aged
,
pubmed-meshheading:12195132-Prospective Studies
,
pubmed-meshheading:12195132-Risk Assessment
pubmed:year
2002
pubmed:articleTitle
Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study.
pubmed:affiliation
Steno Diabetes Centre, Gentofte, Denmark. larsh.lindholm@fammed.umu.se
pubmed:publicationType
Journal Article
,
Clinical Trial
,
Randomized Controlled Trial
,
Research Support, Non-U.S. Gov't